DocGo (DCGO) Stock Forecast & Price Target

DocGo is well-positioned to see increased profitability and growth through their Mobile Health Services segment, as well as potential synergy from their recent acquisition of Hicuity Health, which brings in high revenue and EBITDA. While cost-cutting measures may take time to show results, a strategic partnership expansion and rationalization of G&A expenses should further boost the company's financial stability in the long-term.

DocGo is currently facing some challenges with profitability, as highlighted by the recent 2Q results where adj. EBITDA and revenue were below consensus. The company's acquisition of Hicuity Health and the assumption of $52 million in debt is a concern, as it may increase the company's costs and limit free cash flow generation in the near-term. While management remains confident in the potential synergies of the deal, there is uncertainty about whether DocGo's mobile health offerings can scale and become significant contributors to the business. This, coupled with the potential headwind of COVID-related testing revenue dissipating in the future, leads to a negative outlook for DocGo's stock.